Cargando…
Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance
Prostate cancer remains an intractable threat to the lives of men worldwide. Although deaths from prostate cancer (PCa) in the United States have declined in recent years, in other parts of the world Pca mortality is increasing. The introduction of 2nd generation anti-androgen receptor agents into t...
Autores principales: | Karanika, Styliani, Karantanos, Theodoros, Yin, Jianhua, Li, Likun, Thompson, Timothy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832885/ https://www.ncbi.nlm.nih.gov/pubmed/29511635 http://dx.doi.org/10.1016/j.ajur.2015.04.004 |
Ejemplares similares
-
DNA damage response and prostate cancer: defects, regulation and therapeutic implications
por: Karanika, Styliani, et al.
Publicado: (2014) -
Immune response after laparoscopic colectomy for cancer: a review
por: Karanika, Styliani, et al.
Publicado: (2013) -
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
por: Karanika, Styliani, et al.
Publicado: (2015) -
976. Development and Validation of a Risk Score for Predicting Cardiovascular Events in HIV-Infected Patients
por: Karanika, Styliani, et al.
Publicado: (2019) -
Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients
por: Karanika, Styliani, et al.
Publicado: (2023)